Infections caused by beta-lactamase-producing Fusobacterium spp. in children.
Brook
I
I
Department of Pediatrics, Georgetown University School of Medicine, Washington, DC.
D000293:Adolescent; D000658:Amoxicillin / Q000627:therapeutic use; D002648:Child; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005673:Fusobacterium / Q000201:enzymology* / Q000302:isolation & purification; D005674:Fusobacterium Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D012189:Retrospective Studies; D013982:Ticarcillin / Q000627:therapeutic use; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000096:biosynthesis*
D002969:Clavulanic Acids; D004338:Drug Combinations; D010406:Penicillins; D065093:beta-Lactamase Inhibitors; D008795:Metronidazole; D019818:Clavulanic Acid; D002981:Clindamycin; D000658:Amoxicillin; D001618:beta-Lactamases; D013982:Ticarcillin